Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study

BACKGROUND: Level I evidence supports the use of sorafenib in patients with Barcelona Clinic Liver Cancer (BCLC) stage C hepatocellular carcinoma, where heterogeneity in efficacy exists due to varying clinicopathologic features of the disease. AIM: We evaluated whether prior treatment with curative...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Liver Cancer
Asıl Yazarlar: Yen, Clarence, Sharma, Rohini, Rimassa, Lorenza, Arizumi, Tadaaki, Bettinger, Dominik, Choo, Huay Yee, Pressiani, Tiziana, Burlone, Michela E., Pirisi, Mario, Giordano, Laura, Abdulrahman, Anisa, Kudo, Masatoshi, Thimme, Robert, Park, Joong Won, Pinato, David James
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: S. Karger AG 2017
Konular:
Original Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5704701/
https://ncbi.nlm.nih.gov/pubmed/29234635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000480441
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller